日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer

外周循环中的ANGPTL3与晚期胃癌抗PD-1治疗耐药相关

Kudo-Saito, Chie; Shoji, Hirokazu; Nagashima, Kengo; Imazeki, Hiroshi; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Boku, Narikazu

Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)

神经内分泌肿瘤 3 级患者系统治疗疗效的多中心回顾性研究 (JOSC-2001)

Okuyama, Hiroyuki; Shibuki, Taro; Okano, Naohiro; Mizukami, Takuro; Yanagimoto, Hiroaki; Okada, Mao; Kita, Emiri; Kobayashi, Noritoshi; Kobayashi, Satoshi; Furukawa, Takaaki; Asama, Hiroyuki; Tsumura, Hidetaka; Kamata, Ken; Umemoto, Kumiko; Hamamoto, Yasuo; Suzuki, Yuko; Horiguchi, Shigeru; Naganuma, Atsushi; Asagi, Akinori; Tsuji, Kunihiro; Takada, Ryoji; Kawata, Kazuhito; Kojima, Motohiro; Imaoka, Hiroshi; Terashima, Takeshi; Ozaka, Masato; Ueno, Makoto; Ikeda, Masafumi

Two cases of metastatic colorectal cancer in which epidermal growth factor receptor gene amplification benefited from panitumumab monotherapy

两例表皮生长因子受体基因扩增的转移性结直肠癌患者受益于帕尼单抗单药治疗

Sato, Taro; Nagashima, Fumio; Okano, Naohiro; Nishioka, Mariko; Hayashi, Masato; Saito, Yuji; Hisamatsu, Tadakazu; Hironaka, Shuichi

Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors

晚期胃肠道肿瘤中基于循环肿瘤DNA分析的靶向治疗

Nakamura, Yoshiaki; Ozaki, Hiroshi; Ueno, Makoto; Komatsu, Yoshito; Yuki, Satoshi; Esaki, Taito; Taniguchi, Hiroya; Sunakawa, Yu; Yamaguchi, Kensei; Kato, Ken; Denda, Tadamichi; Nishina, Tomohiro; Takahashi, Naoki; Satoh, Taroh; Yasui, Hisateru; Satake, Hironaga; Oki, Eiji; Kato, Takeshi; Ohta, Takashi; Matsuhashi, Nobuhisa; Goto, Masahiro; Okano, Naohiro; Ohtsubo, Koushiro; Yamazaki, Kentaro; Yamashita, Riu; Iida, Naoko; Yuasa, Mihoko; Bando, Hideaki; Yoshino, Takayuki

Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial

改良氟尿嘧啶、亚叶酸钙、伊立替康和奥沙利铂或S-1、伊立替康和奥沙利铂对比白蛋白紫杉醇+吉西他滨治疗转移性或复发性胰腺癌(GENERATE,JCOG1611):一项随机、开放标签的II/III期试验

Ohba, Akihiro; Ozaka, Masato; Mizusawa, Junki; Okusaka, Takuji; Kobayashi, Satoshi; Yamashita, Taro; Ikeda, Masafumi; Yasuda, Ichiro; Sugimori, Kazuya; Sasahira, Naoki; Ikezawa, Kenji; Miki, Ikuya; Okano, Naohiro; Mizuno, Nobumasa; Furukawa, Masayuki; Shirakawa, Hirofumi; Sano, Yusuke; Katayama, Hiroshi; Furuse, Junji; Ueno, Makoto

IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer

IL33-ST2轴是晚期胃癌抗PD-1治疗疗效的预测性生物标志物

Kudo-Saito, Chie; Imazeki, Hiroshi; Nagashima, Kengo; Shoji, Hirokazu; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Ichikawa, Hitoshi; Boku, Narikazu

Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

更正:脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)

老年不可切除胆道癌患者的联合化疗:一项采用倾向评分匹配分析的前瞻性观察研究(JON2104-B)

Kobayashi, Satoshi; Nakachi, Kohei; Yamamoto, Kouji; Ueno, Makoto; Maruki, Yuta; Ikezawa, Kenji; Terashima, Takeshi; Shimizu, Satoshi; Oshima, Kotoe; Tsuji, Kunihiro; Masaki, Yoshiharu; Tsumura, Hidetaka; Shibuki, Taro; Ozaka, Masato; Okano, Naohiro; Okamura, Yukiyasu; Umemoto, Kumiko; Satoh, Tatsunori; Kojima, Yasushi; Shioji, Kazuhiko; Nebiki, Hiroko; Doi, Toshifumi; Naganuma, Atsushi; Kataoka, Shigeki; Kita, Emiri; Asama, Hiroyuki; Tsuchiya, Kaoru; Unno, Michiaki; Ashida, Reiko; Matsumoto, Kazuyuki; Ohno, Izumi; Itoi, Takao; Negoro, Yuji; Sakamoto, Yasunari; Arima, Shiho; Asagi, Akinori; Okuyama, Hiroyuki; Komatsu, Yoshito; Kobayashi, Noritoshi; Nagano, Hiroaki; Furuse, Junji

Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

实体瘤中 CLDN18 表达和亚型分布的景观分析:来自 MONSTAR-SCREEN-2 研究的启示

Hashimoto Tadayoshi, Iida Naoko, Nakamura Yoshiaki, Nonomura Norio, Morizane Chigusa, Iwata Hiroji, Okano Susumu, Yamagami Wataru, Yamazaki Naoya, Kadowaki Shigenori, Ueno Makoto, Boku Shogen, Oki Eiji, Komatsu Yoshito, Yuki Satoshi, Makiyama Akitaka, Ogata Takatsugu, Takahashi Naoki, Okano Naohiro, Nishina Tomohiro, Sakamoto Naoya, Kuwata Takeshi, Yamashita Riu, Shibuki Taro, Imai Mitsuho, Fujisawa Takao, Bando Hideaki, Shitara Kohei, Yoshino Takayuki